参考文献/References:
[1]张秀娟,李庆云,徐华俊. 睡眠呼吸暂停模式间歇低氧动物模型的建立及应用[J].中华结核和呼吸杂志, 2011,34(10):777-779.
[2]Jain SK,Kahlon G,Morehead L,et al.The effect of sleep apnea and insomnia on blood levels of leptin, insulin resistance, IP-10, and hydrogen sulfidein type 2 diabetic patients[J].Metab Syndr Relat Disord,2012,10(5):331-336.
[3]Resnick HE, Redline S, Shahar E, et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study[J].Diabetes Care,2003,26(3): 702-709.
[4]Kim SP, Ellmerer M, Van Citters GW, et al. Primacy of hepatic insulin resistance in the development of themetabolic syndrome induced by and isocaoric moderatefat diet in the dog[J].Diabetes,2003, 52 (10): 2453-2460.
[5]Xu W,Chi L,Row BW, et al. Increased oxidative stress is associated with chronic intermittent hypoxiamediated brain conical neuronal cell apoptosis a mouse model of sleep apnea[J]. Neurescience, 2004, 126(2):313-323.
[6]Edmison J, McCullough AJ. Pathogenesis of nonalcoholicsteatohepatitis: human data[J].Clin Liver Dis,2007,2(1):75-104.
[7]Polyzos SA, Kountouras J, Zavos C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines[J]. Curr Mol Med, 2009, 9(3): 299-314.
[8]Orlik B, Handzlik G, Olszanecka Glinianowicz M. The role of adipokines and insulin resistance in the pathogenesis of nonalcoholic fatty liver disease[J].Postepy Hig Med Dosw (online), 2010,64:212-219.
[9]Gconzález Navarro H,Vinué A, Vila Caballer M,et al.Molecular mechanism of atherosclerosis in metabolic syndrom: role of reduced IRS2dependent signaling[J]. Arterioseler Thromb Vasc Biol, 2008, 28(12):2187-2194.
[10]Valverde AM, Burks DJ, Fabregat I, et al. Molecular mechanisms of insulin resistance in IRS-2deficient hepatocytes[J]. Diabetes,2003,52 (9):2239-2248.
[11]Escribano O, Arribas M, Valverde AM, et al. IRS-3 mediates insulin induced glucose uptake in differentiated IRS-2(-/-) brown adipocytes[J]. Mol Cell Endocrinol, 2007, 268(1-2): 1-9.
[12]Zhang W, Patil S, Chauhan B, et al. FoxO1regulates multiple metabolie pathways in the liver: effects on gluconeogenic, glyeolytie, and lipogenic gene expression[J].Biol Chem,2006, 281(15):10105-10117.
[13]Buteau J, Spatz ML, Accili D. Transcription factor FoxO1 mediates glucagon like peptide-1 effects on pancreatic beta cell mass[J].Diabetes, 2006, 55 (5): 1190-1196.
[14]邱秀英,韩继武,李姣姣.PI3K/Akt及其靶蛋白FoxO1与非酒精性脂肪性肝病[J].现代生物医学进展, 2012, 21(23):4584-4587.